Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3051
PUT
Amprius Technologies
AMPX
$1.25B
| $968K | ﹤0.01% |
100,000
| – | – |
2026 Q2
1 quarter
|
|
3052
CALL
Flex
FLEX
$29.2B
| $968K | ﹤0.01% |
+8,800
| New | +$1.04M |
2026 Q3
0 quarters
|
|
3053
Tiptree Inc
TIPT
$642M
| $967K | ﹤0.01% |
56,915
+4,823
| +9% | +$86.4K |
2022 Q2
17 quarters
|
|
3054
Innoviva
INVA
$1.34B
| $965K | ﹤0.01% |
45,516
-124,014
| -73% | -$2.63M |
2013 Q2
53 quarters
|
|
3055
iShares MSCI Australia ETF
EWA
$1.25B
| $965K | ﹤0.01% |
34,079
+9,900
| +41% | +$289K |
2022 Q1
18 quarters
|
|
3056
Biglari Holdings Class B
BH
$1.2B
| $965K | ﹤0.01% |
2,805
+235
| +9% | +$89.2K |
2016 Q1
42 quarters
|
|
3057
Kearny Financial
KRNY
$586M
| $960K | ﹤0.01% |
104,783
+12,709
| +14% | +$122K |
2013 Q2
53 quarters
|
|
3058
Immunocore
IMCR
$1.63B
| $959K | ﹤0.01% |
31,673
+2,156
| +7% | +$73.3K |
2022 Q1
18 quarters
|
|
3059
First Tracks Biotherapeutics
TRAX
$2.12B
| $955K | ﹤0.01% |
26,954
+18,937
| +236% | +$739K |
2026 Q2
1 quarter
|
|
3060
National Beverage
FIZZ
$3.44B
| $953K | ﹤0.01% |
32,644
+11,947
| +58% | +$377K |
2013 Q2
53 quarters
|
|
3061
ProShares VIX Short-Term Futures ETF
VIXY
$169M
| $953K | ﹤0.01% |
56,256
+12,273
| +28% | +$233K |
2024 Q1
10 quarters
|
|
3062
DELISTED
LiveRamp
RAMP
| $953K | ﹤0.01% |
25,397
-5,963
| -19% | -$225K |
2013 Q2
53 quarters
|
|
3063
Ecovyst
ECVT
$1.18B
| $952K | ﹤0.01% |
96,831
+47,626
| +97% | +$524K |
2022 Q1
18 quarters
|
|
3064
Recursion Pharmaceuticals
RXRX
$2.24B
| $951K | ﹤0.01% |
230,273
+112,213
| +95% | +$380K |
2022 Q1
18 quarters
|
|
3065
Liberty Latin America Class C
LILAK
$1.92B
| $951K | ﹤0.01% |
115,661
+95,423
| +472% | +$780K |
2015 Q3
44 quarters
|
|
3066
Westamerica Bancorp
WABC
$1.38B
| $945K | ﹤0.01% |
16,200
-3,231
| -17% | -$192K |
2016 Q2
41 quarters
|
|
3067
PUT
Monolithic Power Systems
MPWR
$72.1B
| $943K | ﹤0.01% |
+700
| New | +$917K |
2026 Q3
0 quarters
|
|
3068
PUT
Charter Communications
CHTR
$15.6B
| $943K | ﹤0.01% |
+8,500
| New | +$1.18M |
2026 Q3
0 quarters
|
|
3069
Progyny
PGNY
$2.69B
| $942K | ﹤0.01% |
37,412
-96,384
| -72% | -$2.73M |
2022 Q1
18 quarters
|
|
3070
Oil-Dri
ODC
$1.06B
| $938K | ﹤0.01% |
10,356
+2,648
| +34% | +$248K |
2022 Q3
16 quarters
|
|
3071
TSS Inc
TSSI
$194M
| $936K | ﹤0.01% |
96,225
+85,712
| +815% | +$833K |
2025 Q2
5 quarters
|
|
3072
Neighborhood Intelligence Inc
NXH
$150M
| $936K | ﹤0.01% |
318,448
-165,923
| -34% | -$727K |
2013 Q2
53 quarters
|
|
3073
Vanda Pharmaceuticals
VNDA
$251M
| $931K | ﹤0.01% |
189,672
+108,022
| +132% | +$580K |
2013 Q2
53 quarters
|
|
3074
Bank of Marin Bancorp
BMRC
$462M
| $928K | ﹤0.01% |
34,267
+7,304
| +27% | +$205K |
2016 Q3
40 quarters
|
|
3075
First Mid Bancshares
FMBH
$1.36B
| $928K | ﹤0.01% |
19,030
+8,968
| +89% | +$451K |
2016 Q2
41 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.